New Enterprise Associates 17, L.P. → Inventiva S.A. IVEVF

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100

Passive Schedule 13G filer baseline
Elevated short days-to-cover (1000.0 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 999.99

97,747 shares short · -51.4% vs prior

Other 13D/G Filings on Inventiva S.A.

Filed	Form	Filer	Stake	Shares
2024-10-21	SC	New Enterprise Associates 17, L.P.	—	—	view →
2024-07-19	SC	BIOTECHNOLOGY VALUE FUND L P	—	—	view →

Other Filings by New Enterprise Associates 17, L.P.

Filed	Form	Issuer	Stake	Shares
2026-07-06	SCHEDULE 13D/A	Monte Rosa Therapeutics, Inc. GLUE	—	6,692,298	view →
2025-10-06	SCHEDULE	NeueHealth, Inc.	—	—	view →
2024-10-21	SC	Inventiva S.A. IVEVF	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →